ImClone Investigational Site

Detroit, Michigan 48202

0 studies enrolling now · 7 studies all time

What they study most

Adipocytic Sarcoma, Advanced Solid Tumors, Colorectal Cancer, Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Leiomyosarcoma, Malignant Solid Tumor, Ovarian Neoplasms, Rhabdomyosarcoma, Synovial Sarcoma

Studies at this site

• A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors — Completed
• A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer — Completed
• A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available — Completed
• A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma — Completed
• A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors — Completed
• Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed